Stefan Reinhold (ESR 14) has published an editorial on the Wnt / β-catenin inhibitor Dickkopf-1 (Dkk1) in this month`s issue of ATVB. The article provides a brief insight into the involvement of Dkk1 serum levels in vascular disease and its potential use as a biomarker to predict cardiovascular and cerebrovascular events.
Click here for the publication
